ARKG
ARK Genomic Revolution ETF [ARKG] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ARKG Stock Summary
Top 10 Correlated ETFs
ARKG
Top 10 Correlated Stocks
ARKG
In the News
ARKG Financial details
Company Rating
-
Market Cap
1.55B
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
3.55%
SMA50
2.71%
SMA100
27.03%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
21.97-38.97
52W High
-15.63%
52W Low
+52.67%
RSI
59.45
Rel Volume
1
Avg Volume
2.5M
Volume
2.51M
Perf Week
1.78%
Perf Month
7.8%
Perf Quarter
23.31%
Perf Half Y
31.77%
-
-
-
-
Beta
1.7
-
-
Volatility
0.65%, 1.05%
Prev Close
-1.44%
Price
32.06
Change
0.72%
Company Profile
- Volume Average 2.5M
- Market Capitalization 1.55B
- Headquarters US
- IPO Date 2014-10-31
The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
